May 1, 2017
CPTR receives $1.1 million grant, partners with TGen to advance TB research
Related Posts
-
C-Path, CDISC Develop Therapeutic Area Standard to Foster More Efficient and Meaningful Research for HIV -
C-Path Receives Qualification from FDA for the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) -
Critical Path Instituteと医薬品医療機器総合機構、初のバイオマーカープロジェクトで協力 -
Critical Path Institute and Japan’s Pharmaceuticals and Medical Devices Agency Collaborate on First-of-its-Kind Biomarker Project
-
C-Path Selects Global Regulatory Affairs Leader as New President and CEO